Artificial Intelligence–Enabled Pharmaceutical Formulation and Drug Delivery: An Integrated Review of Formulation Technologies, Phytopharmaceuticals, and Oncology Applications

##plugins.themes.academic_pro.article.main##

Dr. Shilpi Agarwal

Abstract

Recent advances in pharmaceutical sciences demonstrate a strong convergence of formulation technology, phytopharmaceutical development, nanomedicine, and artificial intelligence (AI). This review integrates published research spanning taste masking technologies, quality-by-design (QbD)–based formulations, 3D printing, nanostructured drug carriers, phytoconstituent extraction, and AI-driven drug delivery and oncology applications. Emphasis is placed on how AI and data-driven approaches are reshaping formulation development, personalized medicine, cancer therapeutics, and healthcare decision-making. The paper also highlights recent trends, patents, and future prospects in intelligent pharmaceutical product development.


 


Keywords: Artificial intelligence, Drug delivery systems, Quality by Design, Phytopharmaceuticals, Nanomedicine, Oncology, Personalized medicine


 

##plugins.themes.academic_pro.article.details##

How to Cite
Dr. Shilpi Agarwal. (2026). Artificial Intelligence–Enabled Pharmaceutical Formulation and Drug Delivery: An Integrated Review of Formulation Technologies, Phytopharmaceuticals, and Oncology Applications. MISJ-International Journal of Medical Research and Allied Sciences, 4(01), Page: 1–5. https://doi.org/10.5281/zenodo.18425647